Research / TOMZ / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-26-004626 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
189.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 55th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.32% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.87% · OPTIONAL · VALID
Revenue growth 57th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
4.91% · CORE · VALID
Inventory pressure 44th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
176.37% · OPTIONAL · VALID
Gross margin 6th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
50.29% · CORE · VALID
Operating margin 56th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
-37.86% · CORE · VALID
R&D intensity 33th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.44% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.01% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/5 normalized Level 3 Mar 31, 2022 0/5 normalized Level 3 Jun 30, 2022 0/5 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/7 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 5/7 normalized Level 3 Dec 31, 2023 5/8 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 5/6 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 6/8 normalized Level 3 Mar 31, 2025 6/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/9 normalized Level 3 Mar 31, 2026 7/9 normalized Level 3 Jun 30, 2026 7/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 55.63%
Current 189.54%
Delta 133.92% Capex Intensity Increased
Previous 0.09%
Current 0.32%
Delta 0.23% Cash Generation Increased
Previous -21.23%
Current 17.87%
Delta 39.10% Growth Increased
Previous -27.17%
Current 4.91%
Delta 32.09% Inventory Pressure Increased
Previous 51.92%
Current 176.37%
Delta 124.45% Margin Decreased
Previous 54.60%
Current 50.29%
Delta -4.31% Profitability Increased
Previous -68.39%
Current -37.86%
Delta 30.53% R And D Intensity Decreased
Previous 5.14%
Current 3.44%
Delta -1.71% Sbc Intensity Decreased
Previous 2.61%
Current 2.01%
Delta -0.60% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.